Skip to main content

Jardiance Dosage

Generic name: EMPAGLIFLOZIN 10mg
Dosage form: tablet, film coated
Drug class: SGLT-2 inhibitors

Medically reviewed by Drugs.com. Last updated on Apr 30, 2025.

Testing Prior to Initiation of JARDIANCE

•
Assess renal function before initiating JARDIANCE and as clinically indicated.
o
Use for glycemic control is not recommended in patients with an eGFR less than 30 mL/min/1.73 m2.
•
Assess volume status. In patients with volume depletion, correct this condition before initiating JARDIANCE.

Recommended Dosage

Table 1 presents the recommended dosage of JARDIANCE in adult and pediatric patients aged 10 years and older.

Table 1 Recommended Dosage of JARDIANCE
Population Indication Recommended Dosage

​Adults

Reduce the risk of cardiovascular death and hospitalization in patients with heart failure

•
10 mg orally once daily in the morning, taken with or without food.

Reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.

Reduce the risk of cardiovascular death in patients with type 2 diabetes mellitus with established cardiovascular disease

Glycemic control in type 2 diabetes mellitus

•
10 mg orally once daily in the morning, taken with or without food.
•
For additional glycemic control, may increase to 25 mg orally once daily in patients tolerating 10 mg once daily.

​Pediatric patients aged 10 years and older

Glycemic control in type 2 diabetes mellitus

•
10 mg orally once daily in the morning, taken with or without food.
•
For additional glycemic control, may increase to 25 mg orally once daily in patients tolerating 10 mg once daily.

Recommendations Regarding Missed Dose

•
​If a dose is missed, instruct patients to take the dose as soon as possible.
•
​Do not double up the next dose.

Temporary Interruption for Surgery

​Withhold JARDIANCE for at least 3 days, if possible, prior to major surgery or procedures associated with prolonged fasting. Resume JARDIANCE when the patient is clinically stable and has resumed oral intake.

Frequently asked questions

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.